Print…

You Searched For: uk122

Corrected to: "uk122"
Other possible search terms:


22  results were found

Refine Results Sort by
SearchResultCount:"22"

Sort Results

List View Easy View

Rate These Search Results

Product Image-75870-444

MycoZap™ Prophylactic

Supplier: Lonza
Description: MycoZap™ Antibiotics are extremely powerful combinations of innovative antibiotics for the protection of cell cultures from mycoplasma contamination. While MycoZap™ Prophylactic prevents mycoplasma contamination, MycoZap™ Plus offers complete protection against a broad range of common contaminants including mycoplasma.

SDS

Product Image-75870-438

MycoZap™ Plus-CL

Supplier: Lonza
Description: MycoZap™ Antibiotics are extremely powerful combinations of innovative antibiotics for the protection of cell cultures from mycoplasma contamination. While MycoZap™ Prophylactic prevents mycoplasma contamination, MycoZap™ Plus offers complete protection against a broad range of common contaminants including mycoplasma.

SDS Certificates

Product Image-75870-440

MycoZap™ Plus-PR

Supplier: Lonza
Description: MycoZap™ Antibiotics are extremely powerful combinations of innovative antibiotics for the protection of cell cultures from mycoplasma contamination. While MycoZap™ Prophylactic prevents mycoplasma contamination, MycoZap™ Plus offers complete protection against a broad range of common contaminants including mycoplasma.

SDS

Product Image-75870-426

MycoZap™ Mycoplasma Elimination Reagent, Lonza

Supplier: Lonza
Description: The MycoZap™ Mycoplasma Elimination Reagent allows efficient mycoplasma removal with minimal impact on cell viability.

SDS Certificates

Image Unavailable-IC19017080

Cyproheptadine hydrochloride sesquihydrate, white powder

Catalog Number: (IC19017080)
Supplier: MP Biomedicals
Description: Cyproheptadine is a Ca2+ channel blocker; 5-HT2 serotonin receptor antagonist; antihistamine, antipruritic. It is a migraine prophylactic.
Image Unavailable-102981-296

Lipid A (from E.coli) ≥99.9%, TLRpure, sterile

Supplier: Adipogen
Description: Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4), a member of the highly conserved protein family of TLRs, which are specialised in the recognition of microbial components. In mice, defects in TLR4 result in LPS unresponsiveness. For optimal interaction with LPS, TLR4 requires association with myeloid differentiation protein 2 (MD-2). According to current consensus activation of TLR4 is preceded by the transfer of LPS to membrane-bound (m) or soluble (s) CD14 by LPS-binding protein (LBP). This mechanism is believed to be generally true for LPS signaling. Re-form LPS and lipid A, but not S-form LPS, are capable of inducing TNF-alpha responses also in the absence of CD14. LPS, synthesized by most wild-type (WT) Gram-negative bacteria (S-form LPS), consists of three regions, the O-polysaccharide chain, which is made up of repeating oligosaccharide units, the core oligosaccharide and the lipid A, which harbors the endotoxic activity of the entire molecule. R-form LPS synthesized by the so-called rough (R) mutants of Gram-negative bacteria lacks the O-specific chain. Furthermore, the core-oligosaccharide may be present in different degrees of completion, depending on the class (Ra to Re) to which the mutant belongs. Monophosphoryl Lipid A (MPLA) represents a detoxified derivative of Lipid A and constitutes an important adjuvant in prophylactic and therapeutic vaccines.

Image Unavailable-102981-264

Lipid A (from Salmonella minnesota) ≥99.9%, TLRpure, sterile

Supplier: Adipogen
Description: Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4), a member of the highly conserved protein family of TLRs, which are specialised in the recognition of microbial components. In mice, defects in TLR4 result in LPS unresponsiveness. For optimal interaction with LPS, TLR4 requires association with myeloid differentiation protein 2 (MD-2). According to current consensus activation of TLR4 is preceded by the transfer of LPS to membrane-bound (m) or soluble (s) CD14 by LPS-binding protein (LBP). This mechanism is believed to be generally true for LPS signaling. Re-form LPS and lipid A, but not S-form LPS, are capable of inducing TNF-alpha responses also in the absence of CD14. LPS, synthesized by most wild-type (WT) Gram-negative bacteria (S-form LPS), consists of three regions, the O-polysaccharide chain, which is made up of repeating oligosaccharide units, the core oligosaccharide and the lipid A, which harbors the endotoxic activity of the entire molecule. R-form LPS synthesized by the so-called rough (R) mutants of Gram-negative bacteria lacks the O-specific chain. Furthermore, the core-oligosaccharide may be present in different degrees of completion, depending on the class (Ra to Re) to which the mutant belongs. Monophosphoryl Lipid A (MPLA) represents a detoxified derivative of Lipid A and constitutes an important adjuvant in prophylactic and therapeutic vaccines.

Image Unavailable-102981-284

MPLA (from E.coli) ≥99.9%, TLRpure, sterile

Supplier: Adipogen
Description: Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4), a member of the highly conserved protein family of TLRs, which are specialised in the recognition of microbial components. In mice, defects in TLR4 result in LPS unresponsiveness. For optimal interaction with LPS, TLR4 requires association with myeloid differentiation protein 2 (MD-2). According to current consensus activation of TLR4 is preceded by the transfer of LPS to membrane-bound (m) or soluble (s) CD14 by LPS-binding protein (LBP). This mechanism is believed to be generally true for LPS signaling. Re-form LPS and lipid A, but not S-form LPS, are capable of inducing TNF-alpha responses also in the absence of CD14. LPS, synthesized by most wild-type (WT) Gram-negative bacteria (S-form LPS), consists of three regions, the O-polysaccharide chain, which is made up of repeating oligosaccharide units, the core oligosaccharide and the lipid A, which harbors the endotoxic activity of the entire molecule. R-form LPS synthesized by the so-called rough (R) mutants of Gram-negative bacteria lacks the O-specific chain. Furthermore, the core-oligosaccharide may be present in different degrees of completion, depending on the class (Ra to Re) to which the mutant belongs. Monophosphoryl Lipid A (MPLA) represents a detoxified derivative of Lipid A and constitutes an important adjuvant in prophylactic and therapeutic vaccines.

Image Unavailable-102981-276

MPLA (from Salmonella minnesota) ≥99.9%, TLRpure, sterile

Supplier: Adipogen
Description: Activation of cells by LPS is mediated by the Toll-like receptor 4 (TLR4), a member of the highly conserved protein family of TLRs, which are specialised in the recognition of microbial components. In mice, defects in TLR4 result in LPS unresponsiveness. For optimal interaction with LPS, TLR4 requires association with myeloid differentiation protein 2 (MD-2). According to current consensus activation of TLR4 is preceded by the transfer of LPS to membrane-bound (m) or soluble (s) CD14 by LPS-binding protein (LBP). This mechanism is believed to be generally true for LPS signaling. Re-form LPS and lipid A, but not S-form LPS, are capable of inducing TNF-alpha responses also in the absence of CD14. LPS, synthesized by most wild-type (WT) Gram-negative bacteria (S-form LPS), consists of three regions, the O-polysaccharide chain, which is made up of repeating oligosaccharide units, the core oligosaccharide and the lipid A, which harbors the endotoxic activity of the entire molecule. R-form LPS synthesized by the so-called rough (R) mutants of Gram-negative bacteria lacks the O-specific chain. Furthermore, the core-oligosaccharide may be present in different degrees of completion, depending on the class (Ra to Re) to which the mutant belongs. Monophosphoryl Lipid A (MPLA) represents a detoxified derivative of Lipid A and constitutes an important adjuvant in prophylactic and therapeutic vaccines.

Image Unavailable-101969-230

MYCOZAP PROPHYLACTIC 10X1 ML

Catalog Number: (101969-230)
Supplier: Lonza
Description: MYCOZAP PROPHYLACTIC 10X1 ML

SDS Certificates

Blocked
Image Unavailable-101969-224

MYCOZAP PLUS-CL (1 X 20 ML)

Catalog Number: (101969-224)
Supplier: Lonza
Description: MYCOZAP PLUS-CL (1 X 20 ML)

SDS Certificates

Blocked
Image Unavailable-101969-226

MYCOZAP PLUS-PR (10 X 1 ML)

Catalog Number: (101969-226)
Supplier: Lonza
Description: MYCOZAP PLUS-PR (10 X 1 ML)

SDS Certificates

Blocked
Image Unavailable-101969-228

MYCOZAP PLUS-PR (1 X 20 ML)

Catalog Number: (101969-228)
Supplier: Lonza
Description: MYCOZAP PLUS-PR (1 X 20 ML)

SDS

Blocked
Image Unavailable-101969-222

MYCOZAP PLUS-CL (10 X 1 ML)

Catalog Number: (101969-222)
Supplier: Lonza
Description: MYCOZAP PLUS-CL (10 X 1 ML)

SDS Certificates

Blocked
Product Image-103258-336

AlumVax Phosphate, OZ Biosciences

Supplier: OZ Biosciences
Description: AlumVax Phosphate is wet gel (colloidal) of aluminum phosphate 2%, provided as a ready-to-use suspension

Product Image-103258-200

AlumVax Hydroxide, OZ Biosciences

Supplier: OZ Biosciences
Description: AlumVax Hydroxide is wet gel (colloidal) of aluminum hydroxide 2%, provided as a ready-to-use suspension

Inquire for Price
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us at 1-800-932-5000.
Stock for this item is limited, but may be available in a warehouse close to you. Please make sure that you are logged in to the site so that available stock can be displayed. If the call is still displayed and you need assistance, please call us at 1-800-932-5000.
This product is marked as restricted and can only be purchased by approved Shipping Accounts. If you need further assistance, email VWR Regulatory Department at Regulatory_Affairs@vwr.com
-Additional Documentation May be needed to purchase this item. A VWR representative will contact you if needed.
This product has been blocked by your organization. Please contact your purchasing department for more information.
The original product is no longer available. The replacement shown is available.
This product is no longer available. Alternatives may be available by searching with the VWR Catalog Number listed above. If you need further assistance, please call VWR Customer Service at 1-800-932-5000.
1 - 16 of 22
no targeter for Bottom